Volpara

Volpara Health is a leading supplier of breast imaging analysis and analytics products aimed at improving clinical decision-making and the early detection of breast cancer. Every day, Volpara software helps clinicians better understand their patients and enables healthcare managers to gain deeper insights into their own health status. Volpara Health has a diverse research team led by internationally recognized experts in medical physics, along with proprietary medical imaging technology supported by multiple patents and trademarks, applying science to address clinical challenges worldwide. The company is certified under ISO27001, ISO13485, and MDSAP 690110 standards in Japan, Australia, Canada, and the United States; it is also a registered institution with the U.S. Food and Drug Administration (FDA), with its products listed accordingly. Additionally, our products bear the CE mark in accordance with the European Medical Device Directive 93/42/EEC.